CROs/Service Providers

PRECOS awarded HTA license, expands PDX drug discovery models

Wednesday, August 22, 2012 11:22 AM

Preclinical Oncology Services (PRECOS), a pre-clinical research and development service provider focused on oncology, has been awarded a license to store and research human tissue samples by the Human Tissue Authority (HTA).

More... »

Cambrex announces significant new supply agreement

Tuesday, August 21, 2012 02:27 PM

Cambrex, a life sciences company based in East Rutherford, N.J., has entered into an non-exclusive agreement to supply an active pharmaceutical ingredient for a customer's phase III program during 2013 and 2014. 

More... »

Almac launches next generation sequencing service for personalized medicine

Tuesday, August 21, 2012 09:10 AM

Global service provider Almac is launching a next generation sequencing (NGS) service to further expand its range of solutions supporting the development of personalized medicine.

More... »

United Drug acquires Bilcare’s clinical trials materials business

Monday, August 20, 2012 11:51 AM

United Drug, an international provider of healthcare services, will acquire the U.K. and U.S. clinical services businesses (combined "Bilcare Global Clinical Supplies" or "Bilcare GCS") from Bilcare Limited for $61 million. The acquisition is expected to be completed on Aug. 31. Bilcare will retain its clinical supplies business in Asia.

More... »

India CRO market to earn $1B by 2016, says Frost & Sullivan

Monday, August 20, 2012 09:44 AM

The CRO market in India earned revenues of $485 million in 2010-11 and is estimated to cross $1.0 billion in 2016, according to new analysis from Frost & Sullivan, “Strategic Analysis of the Clinical Research Organization Market in India.”

More... »

Biomedical Systems to collaborate with Mass. General Hospital

Friday, August 17, 2012 03:19 PM

The imaging division of Biomedical Systems, a global provider of centralized diagnostic services, has formed a collaboration with Massachusetts General Hospital (MGH) to evaluate the efficacy of new drugs and devices.

More... »

IMS Health acquires TTC, strengthens pharma R&D services capabilities

Friday, August 17, 2012 11:27 AM

IMS Health, a global provider of information, services and technology for the healthcare industry, has acquired TTC, a Philadelphia-based benchmarking solutions and analytics company that helps life sciences organizations around the world plan for and negotiate the costs of clinical trials.

More... »

Ark Therapeutics signs a letter of intent with EMD Millipore

Friday, August 17, 2012 11:13 AM

Ark Therapeutics, a London-based contract development and manufacturing company focused on viral product, has signed a non-binding letter of intent with EMD Millipore, a division of Merck, to enter into a collaborative agreement in the field of viral based bioengineered vaccines and other live viral products manufacturing. 

More... »

INC Research promotes Macdonald to CEO, Ogle to continue as chairman

Friday, August 17, 2012 07:42 AM

Raleigh, N.C.-based INC Research, a therapeutically focused CRO has, as part of a planned succession, promoted Chief Operating Officer Jamie Macdonald to president and Chief Executive Officer. Chairman and CEO James T. Ogle will continue to serve as chairman.

More... »

IMS Health expands suite of syndicated analytics with PharmaDeals acquisition

Wednesday, August 15, 2012 11:22 AM

IMS Health, a provider of information, services and technology for the healthcare industry, has acquired PharmaDeals, a provider of online information about business transactions, licensing, and mergers and acquisitions activity within the global pharmaceutical industry.

More... »